Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DxOrange is a private Dutch life sciences consulting company focused on strategy, commercialization, business development, and transaction support for the global biotech, diagnostics, genomics, and vaccine sectors. Founded in 2009 by Dr. Jan Groen, the company provides C-level advisory services spanning organizational strategy, due diligence, fundraising support, market positioning, reimbursement, clinical trial design, and licensing-related guidance. Its sector focus includes molecular diagnostics, immuno diagnostics, point-of-care, companion diagnostics, pharma, and vaccine development rather than operating a disclosed therapeutic drug pipeline of its own. DxOrange appears to function primarily as a specialized advisory and commercialization partner to biotech and healthcare stakeholders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DxOrange.